July 30 (Reuters) – Iksuda Therapeutics: * IKSUDA RECEIVES US FDA IND CLEARANCE FOR IKS04 Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
UPDATE 2-Britain's BAE Systems lifts 2026 outlook as defence orders soar
(Recasts with CEO comments from paragraph 2, adds share price in paragraph 5, analyst comment…
Samsung sees chip shortage extending to 2028, touts long-term supply deals
By Hyunjoo Jin and Heekyong Yang SEOUL, July 30 (Reuters) - Samsung Electronics on Thursday…
Asia stock-picking hedge funds set for record monthly loss, Goldman says
By Summer Zhen HONG KONG, July 30 (Reuters) - Asia-focused equity hedge funds are heading…
